MEthods of ASsessing blood pressUre: identifying thReshold and target valuEs (MeasureBP): A Review & Study Protocol

Current Hypertension Reports

Volumn 17, Issue 4, 2015, Pages 1-9

  Blom, Kimberly C ^a   Farina, Sasha ^b   Gomez, Yessica Haydee ^b   Campbell, Norm R C ^c   Hemmelgarn, Brenda R ^d   Cloutier, Lyne ^e   McKay, Donald W ^f   Dawes, Martin ^g   Tobe, Sheldon W ^a   Bolli, Peter ^h   Gelfer, Mark ^g   McLean, Donna ⁱ   Bartlett, Gillian ^j   Joseph, Lawrence ^k   Featherstone, Robin ^l   Schiffrin, Ernesto L ^m   Daskalopoulou, Stella S ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^f MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j MCGILL UNIVERSITY   (Canada)

^k ROYAL VICTORIA HOSPITAL   (Canada)

^l UNIVERSITY OF ALBERTA   (Canada)

^m MCGILL UNIVERSITY   (Canada)

more..

Author keywords

Blood pressure determination; Blood pressure monitors; Hypertension; Meta analysis; Practice guidelines as topic; Systematic review

Indexed keywords

ADULT; AGE DISTRIBUTION; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL PRACTICE; CONSENSUS; COST EFFECTIVENESS ANALYSIS; DELPHI STUDY; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; MALE; META ANALYSIS (TOPIC); PATIENT CARE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; SMOKING HABIT; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY;

ANIMALS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; REPRODUCIBILITY OF RESULTS;

EID: 84925140123     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-015-0533-5     Document Type: Review

References (75)

1. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13.
2. Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347–60.
3. Vasan R, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men—The Framingham Heart Study. JAMA. 2002;287(8):1003–10.
4. World Health Organization. 2005. Preventing chronic diseases: a vital investment. vi-178. Geneva, Switzerland.
5. Lawes C, Vander Hoorn S, Law M, et al. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006;24(3):423–30.
6. Lawes CMM, Vander Hoorn S, Rodgers A. Int Soc Hypertens. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513–8.
7. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
8. Smith SC, Blaire SN, Criqui MH, et al. Preventing heart-attack and death in patients with coronary-disease. Circulation. 1995;92(1):2–4.
9. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.
10. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States a policy statement from the American heart association. Circulation. 2011;123(8):933–44.
11. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.
12. Kannel W. Blood pressure as a cardiovascular risk factor—prevention and treatment. JAMA. 1996;275(20):1571–6.
13. Myers MG, Godwin M, Dawes M, et al. Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension. 2010;55(2):195–200.
14. Campbell N, McKay D. Accurate blood pressure measurement: why does it matter? CMAJ. 1999;161(3):277–8.
15. Rutan GH, Kuller LH, Neaton JD, et al. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the multiple risk factor intervention TRIAL. Circulation. 1988;77(3):504–14.
16. Perloff D, Grim C, Flack J, et al. Human blood-pressure determination by sphygmomanometry. Circulation. 1993;88(5):2460–70.
17. Campbell NRC, Myers MG, McKay DW. Is usual measurement of blood pressure meaningful? Blood Press Monit. 1999;4(2):71–6.
18. Dasgupta K, Quinn RR, Zarnke KB, et al. The 2014 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2014;30(5):485–501. Manuscript outlines current Canadian recommendations for blood pressure measurement and management. It provides an evidence-based summary of the literature with easy-to-access information for health care providers.
19. Cohen DL, Townsend RR. In the clinic. Hypertension. Ann Intern Med. 2008;149(11):ITC6–1.
20. National Clinical Guidelines Centre. 2004. Hypertension: the clinical management of primary hypertension in adults. 1-310. London, United Kingdom.
21. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults report From the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.
22. Rosendorff C, Black HR, Cannon C, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American heart association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention. Circulation. 2007;115(21):2761–88.
23. Sanchez RA, Ayala M, Baglivo H, et al. Latin American guidelines on hypertension. J Hypertens. 2009;27(5):905–22.
24. Daskalopoulou SS, Khan NA, Quinn RR, et al. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol. 2012;28:270–87.
25. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.
26. McKay DW. Measuring blood pressure: a call to bare arms? CMAJ. 2008;178(5):591–3.
27. Staessen J, O'Brien E, Thijs L, Fagard R. Modern approaches to blood pressure measurement. Occup Environ Med. 2000;57(8):510–20.
28. Campbell NRC, Conradson HE, Kang J, et al. Automated assessment of blood pressure using BpTRU compared with assessments by a trained technician and a clinic nurse. Blood Press Monit. 2005;10(5):257–62.
29. Grassi G, Bombelli M, Seravalle G, et al. Role of ambulatory blood pressure monitoring in resistant hypertension. Curr Hypertens Rep. 2013;15(3):232–7.
30. Kang Y, Li Y, Wang J. Ambulatory blood pressure monitoring in the prediction and prevention of coronary heart disease. Curr Hypertens Rep. 2013;15(3):167–74.
31. Zheng Y, Yan BP, Zhang Y, et al. Wearable cuff-less PTT-based system for overnight blood pressure monitoring. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:6103–6.
32. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American heart association council on high blood pressure research. Circulation. 2005;111(5):697–716.
33. McCormack T, Krause T, O'Flynn N. Management of hypertension in adults in primary care: NICE guideline. Br J Gen Pract. 2012;62(596):163–4.
34. Campbell NRC, Hemmelgarn BR. New recommendations for the use of ambulatory blood pressure monitoring in the diagnosis of hypertension. CMAJ. 2012;184(6):633–4. Manuscript provides a brief, easy-to-read summary of current recommendations for the use of ambulatory blood pressure monitoring in the diagnosis of hypertension. It also outlines current uncertainties surrounding exact therapeutic thresholds for some automated blood pressure measurement devices.
35. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama. Jpn J Hypertens. 1998;16(7):971–5.
36. Tsuji I, Imai Y, Nagai K, et al. Proposal of reference values for home blood pressure measurement. Am J Hypertens. 1997;10(4):409–18.
37. Thijs LCS, Staessen JA, Celis H, et al. Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med. 1998;158(5):481–8.
38. Agarwal R, Andersen M. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69(2):406–11.
39. Mallion J, Genes N, Vaur L, et al. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study. J Hum Hypertens. 2001;15(12):841–8.
40. Stergiou GS, Baibas NM, Kalogeropoulos PG. Cardiovascular risk prediction based on home blood pressure measurement: the Didima study. J Hypertens. 2007;25(8):1590–6.
41. Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure—the strong heart study. Hypertension. 2007;50(1):197–203.
42. Protogerou AD, Argyris AA, Papaioannou TG, et al. Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: the SAFAR study. J Hypertens. 2014;32(9):1805–14.
43. Leenen FHH, Schiffrin EL. Control rates of hypertension in North America. Hypertension. 2010;56(4):571–2.
44. Thijs L, Staessen JA, Celis H, et al. Reference values for self-recorded blood pressure—a meta-analysis of summary data. Arch Intern Med. 1998;158(5):481–8.
45. Myers MG, McInnis NH, Fodor GJ, Leenen FH. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens. 2008;21(3):280–3.
46. Campbell NRC, Culleton BW, McKay DW. Misclassification of blood pressure by usual measurement in ambulatory physician practices. Am J Hypertens. 2005;18(12):1522–7.
47. Joffres MR, Hamet P, Rabkin SW, et al. Prevalence, control and awareness of high blood-pressure among Canadian adults. CMAJ. 1992;146(11):1997–2005.
48. Jones DW, Appel LJ, Sheps SG, et al. Measuring blood pressure accurately—new and persistent challenges. JAMA. 2003;289(8):1027–30.
49. Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123(3):A12–3.
50. Mattu G, Perry T, Wright J. Comparison of the oscillometric blood pressure monitor (BIRM-100(beta)) with the auscultatory mercury sphygmomanometer. Blood Press Monit. 2001;6(3):153–9.
51. Mattu GS, Heran BS, Wright JM. Overall accuracy of the BpTRU(TM)-an automated electronic blood pressure device. Blood Press Monit. 2004;9(1):47–52.
52. Lamarre-Cliche M, Cheong NNG, Larochelle P. Comparative assessment of four blood pressure measurement methods in hypertensives. Can J Cardiol. 2011;27(4):455–60.
53. Myers MG, Valdivieso MA. Use of an automated blood pressurerecording device, the BpTRU, to reduce the “white coat effect” in routine practice. Am J Hypertens. 2003;16(6):494–7.
54. Myers MG. Automated blood pressure measurement in routine clinical practice. Blood Press Monit. 2006;11(2):59–62.
55. Myers MG, Godwin M, Dawes M, et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. BMJ. 2011;342:d286.
56. Chio S, Urbina EM, LaPointe J, et al. Korotkoff sound versus oscillometric cuff sphygmomanometers: comparison between auscultatory and DynaPulse blood pressure measurements. JASH. 2011;5(1):12–20.
57. Eguchi K, Kuruvilla S, Ishikawa J, et al. Correlations between different measures of clinic, home, and ambulatory blood pressure in hypertensive patients. Blood Press Monit. 2011;16(3):142–8.
58. Erdem E, Aydogdu T, Akpolat T. Validation of the Medisana MTP plus upper arm blood pressure monitor, for self-measurement, according to the European society of hypertension international protocol revision 2010. Blood Press Monit. 2011;16(1):43–6.
59. Graves J, Nash C, Burger K, et al. Clinical decision-making in hypertension using an automated (BpTRU (TM)) measurement device. J Hum Hypertens. 2003;17(12):823–7.
60. Culleton BF, McKay DW, Campbell NR. Performance of the automated BpTRU(TM) measurement device in the assessment of white-coat hypertension and white-coat effect. Blood Press Monit. 2006;11(1):37–42.
61. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord. 2005;5(1):18.
62. Godwin M, Birtwhistle R, Delva D, et al. Manual and automated office measurements in relation to awake ambulatory blood pressure monitoring. Fam Pract. 2011;28(1):110–7.
63. Yi J, Wan Y, Pan F, et al. Validation of the Medipro MediCare 100f upper arm blood pressure monitor, for self-measurement, according to the European society of hypertension international protocol revision 2010. Blood Press Monit. 2011;16(4):197–9.
64. Wright J, Mattu G, Perry T, et al. Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit. 2001;6(3):161–5.
65. Powers BJ, Olsen MK, Smith VA, et al. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011;154(12):781–U29.
66. Campbell NRC, McKay DW, Conradson H, et al. Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-medial thickness in male firefighters. J Hum Hypertens. 2007;21(7):588–90.
67. Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy Studies. Ann Intern Med. 2011;155(8):529–U104.
68. Pai M, McCulloch M, Gorman JD, et al. Systematic reviews and meta-analyses: an illustrated, step-by-step guide. Natl Med J India. 2004;17(2):86–95.
69. Linstone HA, Turoff M. The Delphi method: techniques and applications. Ed: Anonymous Reading. Massachusetts: Addison-Wesley, Advanced Book Program; 1975.
70. Waltz CF. Measurement in nursing and health research. Ed: Strickland O and Lenz, ER. 4th ed. New York, NY: Springer Pub.; 2010.
71. Boggia J, Asayama K, Li Y, et al. Cardiovascular risk stratification and blood pressure variability on ambulatory and home blood pressure measurement. Curr Hypertens Rep. 2014;16(9):470. Manuscript outlines the critical role of blood pressure level in refining cardiovascular risk prediction, over and above other variability indices such as ambulatory blood pressure measurement or home blood pressure measurement.
72. Klarenbach SW, McAlister FA, Johansen H, et al. Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension. Can J Cardiol. 2010;26(5):e158–63.
73. Balu S. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines. Clin Ther. 2009;31(7):1581–94.
74. Parra D, Hough A. Current therapeutic approaches to cardio-protection in hypertension. Curr Hypertens Rep. 2014;16(8):457.
75. Myers MG, Valdivieso M, Kiss A. Consistent relationship between automated office blood pressure recorded in different settings. Blood Press Monit. 2009;14(3):108–11.